Sohonos 1.5 mg

SOHONOS 1.5 MG capsules contain palovarotene, a medication used for managing conditions related to bone growth. This oral treatment is designed to help regulate bone development and is available in a 1.5 MG strength.

SOHONOS 1.5 MG capsules are primarily used to manage conditions associated with abnormal bone growth. Palovarotene, the active ingredient, works to regulate bone development, making it suitable for conditions where bone growth needs to be controlled. This medication is often considered for its potential to address specific bone-related disorders.

Common effects of SOHONOS 1.5 MG capsules may include changes in bone growth patterns. Some users might experience mild gastrointestinal discomfort or other typical side effects associated with oral medications. It's important to monitor any unusual symptoms and consult a healthcare provider if needed.

SOHONOS 1.5 MG capsules should be handled with care, following the prescribed guidelines. It's essential to store the medication properly and adhere to any specific instructions provided by the healthcare provider. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

SOHONOS 1.5 MG capsules may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Always consult a healthcare provider before starting any new medication while taking palovarotene.